Abstract: Sharpless asymmetric dihydroxylation of styrene derivative 6 afforded chiral triols (R)-7 and (S)-
Introduction
The σ receptor was firstly described in 1976 by Martin et al. It was named after the ligand SKF-10047 and initially regarded as opioid receptor subtype [1] . Further research resulted in the classification of σ receptors as a distinct receptor class. In 1990, the existence of at least two σ receptor subtypes was discovered, which were named σ 1 and σ 2 receptor [2] . The σ 1 receptor has been cloned from different species and tissues including guinea pig liver [3] , mouse and rat brain and a human placental tumor cell line. The transmembrane protein consists of 223 amino acids [4] with a molecular weight of 25.3 kDa. A homology with another known mammalian protein was not found, but a 30% homology with the yeast enzyme sterol-Δ 8 /Δ 7 -ismerase, encoded by the gene ERG2, was detected [3] . The σ 1 receptor has not been crystallized so far, but a structural model was published in 2002 [5] and a 3D homology model was established in 2011 [6] . σ 1 receptors are found in the central nervous system [7] , but also in peripheral organs, like liver, kidney [8] and heart [9] . Endogenous ligands have not been clearly identified so far, although some neurosteroids (e.g., progesterone, dehydro-epiandrosterone) and N,N-dimethyltryptamine were proposed as endogenous ligands [10, 11] . The σ 1 receptor is supposed to have an influence the permeability of ion channels [12, 13] and the activity of neurotransmitter systems [14, 15] . In 2007, Hayashi and Su postulated the role of the σ 1 receptor as a ligand-operated chaperon [16] .
Because of the manifold modulatory effects of the σ 1 receptor, potent and selective σ 1 receptor ligands represent potential therapeutics mainly for neurological and psychiatric diseases such as Alzheimer's Disease [17] , neuropathic pain [18] , schizophrenia [19, 20] and Major Depression [15, 21, 22] . PET tracers, which are able to label selectively σ 1 receptors, are of high interest not only to gain further insight into the physiological role of the σ 1 receptor, but also for the diagnosis of diseases in which the σ 1 receptor is involved.
A number of PET tracers for the imaging of σ 1 receptors, labeled with [ [27] [28] [29] [30] [31] . Moreover, (R)-and (S)-configured enantiomers of 2a-c (n = 1-3) were prepared and it was shown that the corresponding enantiomers differ considerably in σ 1 receptor affinity, selectivity over the σ 2 subtype, rate of biotransformation and number and nature of formed metabolites. Additionally, the accumulation of the enantiomeric fluorinated PET tracers in the central nervous system was considerably different [32] [33] [34] . The fluoroalkyl substituted 2-benzofurans 2a-d (n = 1-4) were derived from the spirocyclic 2-benzofuran 1; the potent σ 1 antagonist 3 represents the lead for the enantiomerically pure 2-benzopyrans 4. Although the 2-benzopyran 3 (K i = 1.3 nM) represents a very potent σ 1 receptor antagonist [35] , enantiomers of 2-benzopyran based σ 1 ligands were not yet investigated. Due to their structural similarity to the spirocyclic 3-substituted 2-benzopyrans 3 [36] and 2-benzofurans 1 and 2, 4-substituted 2-benzopyrans 4 were considered as new type of σ 1 receptor ligands. Moreover, the 2-benzopyran scaffold was not exploited for the development of a fluorinated PET tracer so far. In this communication we report the first enantioselective synthesis of 4-substituted spirocyclic 2-benzopyrans of type 4, their affinity towards σ receptors and the generation and biological evaluation of a [ 18 F]-labeled PET tracer based on this scaffold.
Experimental

Synthesis
General
Solvents: THF: distilled from sodium/benzophenone; CH 2 Cl 2 : distilled from calcium hydride. Flash chromatography: silica gel 60 (40-63 µm); parentheses include: diameter of the column (ø), height of the stationary phase (h), eluent and fraction size (V). Thin layer chromatography: TLC silica gel 60 F 254 on aluminum sheets. Melting points (mp): uncorrected. Polarimetry: sodium D line (589 nm); length (l): 1 dm; temperature +20 °C; unit of specific rotation [deg mL dm 
Synthetic Procedures
tert-Butyl-4-hydroxy-4-(2-vinylphenyl)piperidine-1-carboxylate (6)
2-Bromostyrene (5, 3.1 g, 16.9 mmol) was dissolved in THF (125 mL). The solution was cooled to −78 °C under N 2 atmosphere. A solution of n-butyllithium in hexanes (15 mL, 24 mmol) was added dropwise and the mixture was stirred for 15 min. Then tert-butyl 4-oxopiperidine-1-carboxylate (4 m, 4.1 g, 20.6 mmol), dissolved in THF (50 mL), was added and the mixture was stirred at −78 °C for 2.5 h. Then the solution was warmed to ambient temperature. A solution of LiBH 4 in THF (5 mL, 20 mmol) was added dropwise and the mixture was stirred for 1 h at ambient temperature. The reaction was stopped by the addition of water and a 1 M aqueous solution of HCl. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography (Ø = 8 cm, h = 16 cm, cyclohexane-ethyl acetate = 9:1, V = 100 mL) to give 6 as a colorless solid (R f = 0.34, cyclohexane-ethyl acetate = 8:2), mp 104 °C, yield 3.83 g (75% 
tert-Butyl
AD-mix-β (27.1 g) was added to a mixture of tert-butyl alcohol (600 mL) and water (600 mL). The mixture was cooled to 0 °C, 6 (5.9 g, 19.5 mmol) was added and the reaction mixture was stirred at 0 °C for 3 d. Then sodium sulfite (29 g ) was added and the mixture was allowed to warm to room temperature and stirred for 20 min. Ethyl acetate was added to the reaction mixture, and after separation of the layers, the aqueous layer was extracted with ethyl acetate (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography (Ø = 8 cm, h = 18 cm, cyclohexane-ethyl acetate = 1:2 → ethyl acetate, V = 100 mL) to give (R)-7 as a colorless solid (R f = 0.11, cyclohexane-ethyl acetate = 5:5), mp 93 °C, yield 5.4 g (82% 
AD-mix-α (15.2 g) was added to a mixture of tert-butyl alcohol (325 mL) and water (325 mL). The mixture was cooled to 0 °C, 6 (4.5 g, 14.9 mmol) was added and the reaction mixture was stirred overnight at 0 °C. Then methanesulfonamide (1.0 g, 10.5 mmol) was added and the mixture was stirred overnight at ambient temperature. Then sodium sulfite (16.2 g) was added and the mixture stirred for 30 min. Ethyl acetate was added to the reaction mixture, and after separation of the layers, the aqueous layer was extracted with ethyl acetate (3×). The combined organic layers were washed with a 2 M aqueous solution of NaOH, dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography (Ø = 8 cm, h = 15 cm, cyclohexane-ethyl acetate = 1:2 → ethyl acetate, V = 100 mL) to give (S)-7 as a colorless solid (R f = 0.11, cyclohexane:ethyl acetate = 5:5), mp 87 °C, yield 2.7 (74%) C 18 
(R)-7 (98 mg, 0.29 mmol) was dissolved in CH 2 Cl 2 (10 mL). 4-Dimethylaminopyridine (12 mg, 0.10 mmol), triethylamine (210 μL, 1.5 mmol) and 4-toulenesulfonyl chloride (110 mg, 0.58 mmol) were added and the mixture was stirred for 3 h at ambient temperature. Then water was added and after separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography (Ø = 2 cm, h = 16 cm, cyclohexane-ethyl acetate = 9:1, V = 10 mL) to give (S)-8 as a colorless oil (R f = 0.28, cyclohexane-ethyl acetate = 8:2), mp 124 °C, yield 69 mg (50% (R)-11 (105 mg, 0.33 mmol) was dissolved in CH 2 Cl 2 (4 mL). The solution was cooled to 0 °C. Then trifluoroacetic acid (200 μL) was added and the mixture was stirred for 3.5 h at 0 °C. Then a 2 M aqueous solution of sodium hydroxide (4 mL) was added, and after separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The residue was dissolved in CH 2 Cl 2 (5 mL), benzaldehyde (35 μL, 0.35 mmol) and sodium triacetoxyborohydride (85 mg, 0.40 mmol) were added and the mixture was stirred overnight at ambient temperature. The reaction was stopped by the addition of a 2 M aqueous solution of sodium hydroxide, and after separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (4×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography (Ø = 1. (R)-11 (56 mg, 0.18 mmol) was dissolved in CH 2 Cl 2 (10 mL). Trifluoroacetic acid (200 μL) was added and the mixture was stirred overnight at ambient temperature. Then water was added, and after separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The residue was dissolved in CH 2 Cl 2 (10 mL), benzaldehyde (50 μL, 0.45 mmol) and sodium triacetoxyborohydride (50 mg, 0.24 mmol) were added and the mixture was stirred for 5.5 h at ambient temperature. Then benzaldehyde (50 μL, 0.35 mmol) and sodium triacetoxyborohydride (60 mg, 0.28 mmol) were added and the mixture was stirred overnight at ambient temperature). The reaction was stopped by the addition of a 2 M aqueous solution of sodium hydroxide, and after separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. 
(R)-10 (210 mg, 0.66 mmol) was dissolved in THF (15 mL). NaH (60% dispersion in paraffin liquid, 80 mg, 2.0 mmol) was added and the mixture was stirred for 1 h at ambient temperature. Then iodoethane (0.53 mL, 6.6 mmol) was added dropwise and the mixture was stirred for 2.5 h at ambient temperature. A 1 m solution of lithium bis(trimethylsilyl)amide (4.5 mL) was added and the mixture was heated to reflux overnight. The mixture was allowed to cool to ambient temperature and stirred overnight. Then water and CH 2 Cl 2 were added. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent removed in vacuo. The crude product was purified by flash column chromatography (Ø = 2 cm, h = 15 cm, cyclohexane-ethyl acetate = 9:1, V = 10 mL) to give (R)-14 as a pale yellow oil (R f = 0.15, cyclo-hexane-ethyl acetate = 9:1), yield 66 mg (29% 
tert-Butyl (S)-4-ethoxy-3,4-dihydrospiro[[2]benzopyran-1,4′-piperidine]-1′-carboxylate ((S)-14)
(S)-10 (200 mg, 0.63 mmol) was dissolved in THF (5 mL). A 1 m solution of lithium bis(trimethylsilyl)amide (6.3 mL) was added and the mixture was stirred for 1 h at ambient temperature. Then iodoethane (500 μL, 6.3 mmol) was added dropwise and the mixture was stirred for 16 h at ambient temperature. NaH (60% dispersion in paraffin liquid, 250 mg, 6.3 mmol) and iodoethane (500 μL, 6.3 mmol) were added and the mixture was heated to reflux overnight. The mixture was allowed to cool to ambient temperature and stirred for 3 days. Then water was added. After separation of the layers, the aqueous layer was extracted with ethyl acetate (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography three times (1. Ø = 2 cm, h = 15 cm, cyclohexane-ethyl acetate = 9:1, V = 10 mL; 2. Ø = 1.5 cm, h = 15 cm, cyclohexane-ethyl acetate = 9:1, V = 5 mL; 3. Ø = 1. 
Spectroscopic data for (R)-14 and (S)-14
(R)-13 (360 mg, 1.1 mmol) was dissolved in CH 2 Cl 2 (5 mL). The solution was cooled to 0 °C. Trifluoroacetic acid (0.7 mL) was added and the mixture was stirred for 2 h at 0 °C. Then a 2 M aqueous solution of NaOH was added. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The residue was dissolved in CH 2 Cl 2 (5 mL). Benzaldehyde (30 μL, 0.30 mmol) and sodium triacetoxyborohydride (76 mg, 0.36 mmol) were added and the mixture was stirred for 26 h at ambient temperature. Then a 2 M aqueous solution of NaOH (3 mL) and water (3 mL) were added. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined (S)-13 (50 mg, 0.15 mmol) was dissolved in CH 2 Cl 2 (5 mL). Trifluoroacetic acid (200 μL) was added and the mixture was stirred for 4.5 h at ambient temperature. Then a 2 M aqueous solution of NaOH was added. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The residue was dissolved in CH 2 Cl 2 (10 mL). Benzaldehyde (70 μL, 0.69 mmol) and sodium triacetoxyborohydride (96 mg, 0.45 mmol) were added and the mixture was stirred overnight at ambient temperature. The reaction was stopped by the addition of a 2 M aqueous solution of NaOH. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography twice (1. Ø = 1. (R)-14 (49 mg, 0.14 mmol) was dissolved in CH 2 Cl 2 (10 mL). Trifluoroacetic acid (200 μL) was added and the mixture was stirred for 3 h at ambient temperature. Then a 2 M aqueous solution of NaOH (10 mL) was added. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The residue was dissolved in CH 2 Cl 2 (10 mL). Benzaldehyde (60 μL, 0.59 mmol) and (after 45 min) sodium triacetoxyborohydride (181 mg, 0.85 mmol) were added and the mixture was stirred overnight at ambient temperature. The reaction was stopped by the addition of a 2 M aqueous solution of NaOH. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (2×) and ethyl acetate (1×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography twice (1. Ø = 1. (S)-14 (63 mg, 0.18 mmol) was dissolved in CH 2 Cl 2 (5 mL). Trifluoroacetic acid (300 μL) was added and the mixture was stirred for 2 h at ambient temperature. Then a 2 M aqueous solution of NaOH was added. After separation of the layers, the aqueous layer was extracted with ethyl acetate (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The residue was dissolved in CH 2 Cl 2 (5 mL). Benzaldehyde (40 μL, 0.39 mmol) and after 15 min, sodium triacetoxyborohydride (120 mg, 0.57 mmol) were added and the mixture was stirred at ambient temperature for 8 h. The reaction was stopped by the addition of a 2 M aqueous solution of NaOH. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography (Ø = 1.25 cm, h = 15 cm, cyclohexane-ethyl acetate = 6:1, V = 5 mL) to give (S)-16 as a pale yellow oil (R f = 0.31, cyclohexane-ethyl acetate = 5:5), yield 28 mg (46% (R)-17 (86 mg, 0.21 mmol) was dissolved in CH 2 Cl 2 (4 mL). Trifluoroacetic acid (200 μL) was added and the mixture was stirred overnight at ambient temperature. Then water was added. After separation of the layers, the aqueous layer was extracted with ethyl acetate (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The residue was dissolved in CH 2 Cl 2 (2 mL). Benzaldehyde (103 μL, 1.0 mmol) and sodium triacetoxyborohydride (161 mg, 0.76 mmol) were added and the mixture was stirred at ambient temperature for 4 days. The reaction was stopped by the addition of a 2 M aqueous solution of NaOH. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The crude product was purified by flash column chromatography (Ø = 1. 
Spectroscopic data for (R)-15 and (S)-15
)
Ethyl (S)-2-[(1′-benzyl-3,4-dihydro-3,4-dihydrospiro[2-benzopyran-1,4′-piperidin]-4-yl)oxy]acetate ((S)-18)
(S)-17 (1.3 mg, 3.2 mmol) was dissolved in CH 2 Cl 2 (60 mL). Trifluoroacetic acid (3.5 mL) was added and the mixture was stirred for 7 h at ambient temperature. Then a 2 M aqueous solution of NaOH was added. After separation of the layers, the aqueous layer was extracted with CH 2 Cl 2 (3×). The combined organic layers were dried (Na 2 SO 4 ), filtered and the solvent was removed in vacuo. The residue was dissolved in CH 2 Cl 2 (50 mL). Benzaldehyde (1.0 mL, 9.9 mmol) and, after 15 min, sodium triacetoxyborohydride (2.0 g, 9.4 mmol) were added and the mixture was stirred overnight at ambient temperature. The reaction was stopped by the addition of a 2 M aqueous solution of NaOH and worked up as described for (R) 
Spectroscopic data for (R)-18 and (S)-18
Spectroscopic data for (R)-19 and (S)-19
Spectroscopic data for (R)-21 and (S)-21
Exact mass (APCI): m/z = 508.2151 (calcd. 508.2152 for C 29 
Receptor Bindings Studies
Materials
The guinea pig brain and rat liver for the σ 1 and σ 2 receptor binding assays were commercially available (Harlan-Winkelmann, Borchen, Germany 
Preparation of Membrane Homogenates from Guinea Pig Brain
According to [35] [36] [37] : five guinea pig brains were homogenized with the Potter (500-800 rpm, 10 up-and-down strokes) in 6 volumes of cold 0.32 M sucrose. The suspension was centrifuged at 1,200 × g for 10 min at 4 °C. The supernatant was separated and centrifuged at 23,500 × g for 20 min at 4 °C. The pellet was resuspended in 5-6 volumes of buffer (50 mM TRIS, pH 7.4) and centrifuged again at 23,500 × g (20 min, 4 °C). This procedure was repeated twice. The final pellet was resuspended in 5-6 volumes of buffer and frozen (−80 °C) in 1.5 mL portions containing about 1.5 mg protein/mL.
Preparation of Membrane Homogenates from Rat Liver
According to [35] [36] [37] : two rat livers were cut into small pieces and homogenized with the Potter (500-800 rpm, 10 up-and-down strokes) in 6 volumes of cold 0.32 M sucrose. The suspension was centrifuged at 1,200 × g for 10 min at 4 °C. The supernatant was separated and centrifuged at 31,000 × g for 20 min at 4 °C. The pellet was resuspended in 5-6 volumes of buffer (50 mM TRIS, pH 8.0) and incubated at room temperature for 30 min. After the incubation, the suspension was centrifuged again at 31,000 × g for 20 min at 4 °C. The final pellet was resuspended in 5-6 volumes of buffer and stored at −80 °C in 1.5 mL portions containing about 2 mg protein/mL.
Protein Determination
The protein concentration was determined by the method of Bradford [38] , modified by Stoscheck [39] . The Bradford solution was prepared by dissolving 5 mg of Coomassie Brilliant Blue G 250 in 2.5 mL of EtOH (95%, v/v). 10 mL deionized H 2 O and 5 mL phosphoric acid (85%, m/v) were added to this solution, the mixture was stirred and filled to a total volume of 50.0 mL with deionized water. The calibration was carried out using bovine serum albumin as a standard in 9 concentrations (0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, 2.0 and 4.0 mg/mL). In a 96-well standard multiplate, 10 µL of the calibration solution or 10 µL of the membrane receptor preparation were mixed with 190 µL of the Bradford solution, respectively. After 5 min, the UV absorption of the protein-dye complex at λ = 595 nm was measured with a platereader (Tecan Genios, Tecan, Crailsheim, Germany).
General Protocol for the Binding Assays
According to [35] [36] [37] : the test compound solutions were prepared by dissolving approximately 10 µmol (usually 2-4 mg) of test compound in DMSO so that a 10 mM stock solution was obtained. To obtain the required test solutions for the assay, the DMSO stock solution was diluted with the respective assay buffer. The filtermats were presoaked in 0.5% aqueous polyethylenimine solution for 2 h at room temperature before use. All binding experiments were carried out in duplicates in 96-well multiplates. The concentrations given are the final concentrations in the assay. Generally, the assays were performed by addition of 50 µL of the respective assay buffer, 50 µL test compound solution in various concentrations (10 mol/L), 50 µL of corresponding radioligand solution and 50 µL of the respective receptor preparation into each well of the multiplate (total volume 200 µL). The receptor preparation was always added last. During the incubation, the multiplates were shaken at a speed of 500-600 rpm at the specified temperature. Unless otherwise noted, the assays were terminated after 120 min by rapid filtration using the harvester. During the filtration each well was washed five times with 300 µL of water. Subsequently, the filtermats were dried at 95 °C. The solid scintillator was melted on the dried filtermats at a temperature of 95 °C for 5 min. After solidifying of the scintillator at room temperature, the trapped radioactivity in the filtermats was measured with the scintillation analyzer. Each position on the filtermat corresponding to one well of the multiplate was measured for 5 min with the [ [40] . The K i -values are given as mean value ± SEM from three independent experiments.
Protocol of the σ 1 Receptor Binding Assay
According to [35] [36] [37] : the assay was performed with the radioligand [ 
Radiochemistry
General
For Solid Phase Extraction (SPE), Sep-Pak ® C18 cartridges Plus, Plus short and Plus light (Waters, Eschborn, Germany) as well as Chromabond HR-X ® cartridges (Machery-Nagel, Düren, Germany) were tried and C18 cartridges Plus were applied routinely.
Analytical radio-HPLC was performed using an Jasco device series 2000 consisting of autosampler, quaternary pump, degasser, UV-Vis detector, and NaI(Tl)-scintillation detector (bte, Braunschweig, Germany) for gamma detection. A Multospher 120 RP18-AQ column (250x4.6 mm, particle size 5 µm p.s.; CS Chromatographie Service, , Langerwehe, Germany) was applied in gradient mode (0-10 min: 5% MeCN+ 20 mM NH 4 OAc aq.; 10-55 min: 10%-80% MeCN + 20 mM NH 4 OAc aq.) at a flow rate of 1.0 mL/min.
Separation of the crude 18 F-labeled product was conducted via semi-preparative radio-HPLC in isocratic mode using a Multospher 120 RP18-AQ column (150×10 mm, 5 µm) with 50% acetonitrile + 20 mM NH 4 OAc aq. as eluent at a flow rate of 2 mL/min. The device consisted of an S1021 pump (SYKAM Chromatographie, Fürstenfeldbruck, Germany), UV detector (Well-ChromK-2001, KNAUER, Berlin, Germany), and NaI(Tl)-counter and data acquisition was performed by NINA software version 4.8 rev. 4 (Nuclear Interface, München, Germany).
Radioluminescence thin-layer chromatography (radio-TLC) was performed on alumina coated platelets (Alugram ® ALOX N/UV 254 ) with petroleum ether/ethyl acetate 7:3 (v/v) as solvent. Radioactive spots were visualised by radioluminescence using a BAS-1800 II system (Bioimaging Analyzer, Fuji Film, Düsseldorf, Germany). Images were evaluated with AIDA 2.31 software (raytest, Straubenhardt, Germany) using the non-radioactive reference compounds after visualization under UV (254 nm). 
Synthesis of [
In vitro stability and lipophilicity of [
Biological Evaluation
General
The experimental protocols were approved by the local ethics committee and conducted according to the national and EU regulations for animal research. Female CD1 mice (10-12 weeks old, 33.8 ± 6.2 g) were obtained from the Medizinisch-Experimentelles Zentrum, Universität Leipzig and housed under a 12 h/12 h light/dark cycle with free access to food and water for at least 24 h before experiments. Animals were sacrificed by CO 2 asphyxiation after anaesthesia with O 2 /CO 2 mixture. . The precipitation of proteins in plasma, brain, and liver samples was performed using twofold extraction of aliquots with ice-cold MeCN (1:4 v/v; for plasma 1:7 v/v), centrifugation of precipitates, and gentle concentration of the combined supernatants (~60°C, argon flow). In addition, precipitation experiments were supplemented by an alternative precipitation method using aqueous MeOH (MeOH/H 2 O 9:1). The percentages of the parent radiotracer and radiometabolites were analysed by radio-HPLC and radio-TLC. The extraction efficiency was controlled using a calibrated γ-counter (Wallac WIZARD, Perkin Elmer).
Ex Vivo Autoradiography Studies
The tracer distribution in the brain under control and blocking conditions was determined by ex vivo autoradiography studies. [ [44] . Animals were sacrificed at 30 min p.i. Blood was collected by heart puncture, the brain quickly removed and transferred on ice, and all samples were weighed. Radioactivity in brain and plasma samples was counted using an automated γ-counter and expressed as percentage of injected dose per gram (%ID/g). For autoradiography, the brain hemispheres were frozen immediately after isolation in 2-methylbutane (Carl Roth, Karlsruhe, Germany) at −30 °C (>2 min). Serial sagittal slices of 12 µm thickness were cut on a cryostat (Microm, Walldorf, Germany) from approx. midline, +500 µm, +1,000 µm and +1,500 µm. Slices were exposed overnight on an imaging plate (SR 2025, Fuji, Tokyo, Japan), scanned afterwards with a high-resolution phosphorimager (HD-CR 35 Bio, raytest). 2D densitometry of the whole brain was performed with AIDA software (raytest).
Results and Discussion
Synthesis
The synthesis of enantiomerically pure 2-benzopyrans of type 4 started with 2-bromostyrene (5). Bromine lithium exchange with n-BuLi at −78 °C led to an aryllithium intermediate, which was treated with 1-Boc-piperidin-4-one to yield the styrene derivative 6. The Boc-protected piperidone was chosen because the handling (work-up, purification, isolation) of the resulting carbamate was much easier than the handling of alternative benzyl substituted tertiary amines (e.g., 12). Removal of the excess of 1-Boc-piperidin-4-one was performed by LiBH 4 reduction of the keto group after complete reaction of the ketone with the lithiated vinylbenzene derivative. Flash chromatographic separation of the resulting 1-Boc-piperidin-4-ol resulted in 75% yield of the tertiary alcohol 6.
The Sharpless Asymmetric Dihydroxylation of terminal alkene 6 with AD-mix-β employing the standard protocol [45] [46] [47] , led only to low yields of diol (R)-7 (Scheme 1). Increasing of the amount of chiral ligand (DHQD) 2 PHAL, oxidant (K 2 OsO 4 ) and cooxidant (Na 3 [Fe(CN) 6 ] and a longer reaction time did not lead to reproducible high yields of diol (R)-7. It was assumed that the reason for the low yields of (R)-7 was the low solubility of alkene 6 in a 1:1 tert-butanol-water solvent mixture. Despite the addition of different cosolvents (e.g., tert-butyl methyl ether, THF) to the solvent mixture, the yields were not improved. However, the yield was considerably raised when increasing the amount of solvent mixture from 10 mL to 60 mL/mmol alkene. The (R)-configured triol (R)-7 was obtained in a reproducible yield of 82%. Analogously the (S)-configured enantiomer (S)-7 was accessible in 74% yield, when using AD-mix-α for the dihydroxylation step.
Reaction of triol (R)-7 with tosyl chloride, NEt 3 and DMAP provided the 2-benzofuran (S)-8 in 50% yield. It is assumed that tosyl chloride reacts predominantly with the primary OH-moiety of triol (R)-7. In the presence of base the resulting primary tosylate forms an oxirane, which is opened by the tertiary alcohol giving the five-membered 2-benzofuran. Finally the primary alcohol reacts with a second equivalent tosyl chloride to form the tosylate (S)-8. Reaction of 2-(2-bromophenyl)oxirane (R)-9 with n-BuLi and subsequently with 1-Boc-piperidin-4-one led to an analogous 2-benzofuran ((S)-10) upon regioselective opening of the oxirane ring by the intermediate lithium alcoholate [35] . Scheme 1. Regioselective synthesis of 2-benzopyrans and 2-benzofurans. However, addition of catalytic amounts of Bu 2 SnO during the tosylation of triol (R)-7 afforded selectively the 2-benzopyran (R)-11, which was isolated in 62% yield. The addition of Bu 2 SnO was crucial for the synthesis of the 2-benzopyran scaffold. Bu 2 SnO is described as additive for the selective tosylation of the primary OH-moiety of diols by shielding the other OH-moiety [48] . In case of triol (R)-7, shielding of the secondary OH-moiety by Bu 2 SnO leads to selective activation (i.e., tosylation) of the primary OH-moiety for the nucleophilic substitution.
The enantiomeric purity of (R)-11 and (S)-11, which was prepared analogously, was analyzed by chiral HPLC using Daicel Chiralpak IB column, resulting in 85% ee for (R)-11 and 77.2% ee for (S)-11. The moderate enantiomeric excess is explained by the high solvent amount used for the Sharpless Asymmetric Dihydroxylation leading to a lower concentration of the chiral alkaloid ligand due to dilution effect. The lower concentration of the chiral catalyst may lead to an increased amount of uncatalyzed dihydroxylation of alkene 6. This effect has already been described in the literature [33] .
For the introduction of the desired benzyl group at the piperidine ring the Boc protective group of (R)-11 was cleaved off with trifluoroacetic acid (TFA). Without further purification, the resulting secondary amine was reductively alkylated with benzaldehyde and NaBH(OAc) 3 to afford the benzyl-substituted alcohol (R)-12. After synthesis of the enantiomer (S)-12, the enantiomeric purity of both enantiomers was determined by chiral HPLC using a Daicel Chiralpak AD-H column, which resulted in 92.2% ee for (R)-12 and 76.2% ee for (S)-12.
The structure of the 2-benzopyran (R)-12 was unambiguously identified by comparison of its NMR spectra with those of the hydroxymethyl substituted 2-benzofuran (S)-10, which was obtained from the oxirane (R)-9 as reported previously by halogen/metal exchange, addition to piperidinone and exchange of the Boc-protective group with a benzyl group [33] . The Since DTG is not selective for the σ 2 subtype over the σ 1 subtype, σ 1 receptors binding sites were masked by addition of non-labeled (+)-pentazocine [35] [36] [37] .
The σ 1 and σ 2 affinities of the spirocyclic 2-benzopyrans are listed in Table 1 As previously reported for other spirocyclic σ 1 receptor ligands [28] , the hydroxy moiety of (R)-11 acting as H-bond donor is unfavorable in terms of high σ 1 receptor affinity (K i = 5.2 nM). Methylation of the OH group led to increased σ 1 affinity. The methyl ether (R)-15 (K i = 1.2 nM) represents the most potent σ 1 receptor ligand of this series of spirocyclic 2-benzopyrans. Larger substituents like an ethyl ((R)-16) or an ethoxycarbonylethyl group ((R)-18) reduced the σ 1 affinity slightly, whereas a substituent with a polar OH group in the side chain resulted in 10-fold reduced σ 1 affinity ((R)-19: K i = 55 nM).
The fluoroethyl derivatives 20 were synthesized having in mind fluorinated PET tracers for labeling of σ 1 receptors in the brain. Due to its similar size the fluorine atom is considered as bioisosteric replacement of a proton, but due its high electronegativity it is also regarded as a bioisostere of an OH moiety. As summarized in Table 1 
Radiosynthesis
For the radiosynthesis of [ The one-step introduction of F-labeled radiotracer by heating in acetonitrile at 82 °C for 20 min. According to radio-TLC and radio-HPLC analyses, only a few radioactive by-products were formed. Thus, the crude reaction mixture was diluted with water to 4 mL and directly applied to semi-preparative HPLC. The radiotracer eluted at ca. 32 min and was completely free from radioactive and non-radioactive impurities. (Figure 3 ) Interestingly, a considerable part of 18 F activity, mainly from highly polar components remained in the stainless steel loop. Using a PEEK loop in the HPLC device resulted in about 80%-90% elution of [ In brain samples (n = 4) the fraction of the non-metabolized radiotracer accounted for 91%-95% (radio-TLC) and 89%-92% (radio-HPLC) with good reproducibility. Only one highly polar (hydrophilic) radiometabolite (M1) was detected. Its retention time (t R 3.6 min) was similar to but not identical with the retention time of [ Results from radio-HPLC and radio-TLC agreed well. The recovery of total radioactivity was 75% for acetonitrile extraction and up to 90% for methanol extraction. The main radiometabolite in plasma samples was the very polar metabolite M1 (80%-90% of total radioactivity at 30 min p.i.). Additionally, two small peaks for metabolites M2 (t R ~24.7 min) and M3 t R ~26.0 min) were detected with an intensity of lower than 3%.
In urine samples (n = 3), a large amount of radiometabolites and a very low amount of the parent radiotracer [ The results obtained by analysis of liver homogenates are based on a single experiment and should be treated with caution. About 50% to 56% of the parent radiotracer [ 
Conclusions
In this manuscript the asymmetric synthesis of spirocyclic 2-benzopyrans in enantiomerically pure form is described for the first time. The key step of the synthesis is the asymmetric dihydroxylation according to Sharpless, which allows the preparation of 4-substituted spirocyclic 2-benzopyrans. These compounds represent a new type of potent and subtype selective σ 1 receptor ligands. Some of the compounds show an eudismic ratio up to 29 (ester 18), indicating an enantioselective interaction of the σ 1 receptor with these ligands. The very potent fluorinated fluoroethoxy derivative (R)-20 was developed as fluorinated PET-tracer. The radiosynthesis based on a one-step nucleophilic substitution of tosylate (R)-21 provided the PET tracer [ 
